← Leaderboards
Paul A Scheet
University Of Tx Md Anderson Can Ctr
$7,895,863
Attributed
$14,369,625
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,460,824 · 10
By mechanism
R01$13,591,184 · 6
U54$1,599,046 · 2
P30$146,869 · 1
R03$123,725 · 1
Top collaborators
- Chad Daniel Huff6 shared
- Humam Kadara4 shared
- Paul L. Auer3 shared
- Alexander Bick3 shared
- Noah Rosenberg3 shared
- Sebastian Zoellner3 shared
- Keila Enitt Torres2 shared
- Sharon Hermes Giordano1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Ruy Lopez Ridaura$1,748,418
- Cullen Mitsuo Taniguchi$3,293,212
- Keila Enitt Torres$1,425,205
- Kathleen Marie Schmainda$14,483,193
- Francisco Vega-Vazquez$2,004,047
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingGeneticVariantGenomeGenomicsMalignant NeoplasmsDetectionPatternAffectHigh RiskGenesSurveysHuman GeneticsDesignPathway InteractionsInsightTechnologyResourcesCohortMalignant Neoplasm Of LungExomeDiagnosisProgramsScreening
Grant awards (35)
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences$682,011
R01 · FY2025 · AG
Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs$530,632
R01 · FY2025 · CA
27 Risk, Detection and Outcomes$24,690
P30 · FY2025 · CA · contact PI
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences$703,426
R01 · FY2024 · AG
Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs$613,597
R01 · FY2024 · CA
Population genetics for large-scale sequencing studies of diverse populations$519,607
R01 · FY2024 · HG
27 Risk, Detection and Outcomes$23,220
P30 · FY2024 · CA · contact PI
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,091,199
U54 · FY2023 · CA
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences$779,363
R01 · FY2023 · AG
Population genetics for large-scale sequencing studies of diverse populations$530,211
R01 · FY2023 · HG
Planning and Evaluation Core (PEC)$507,847
U54 · FY2023 · CA · contact PI
27 Risk, Detection and Outcomes$18,707
P30 · FY2023 · CA · contact PI
Population genetics for large-scale sequencing studies of diverse populations$558,911
R01 · FY2022 · HG
27 Risk, Detection and Outcomes$18,707
P30 · FY2022 · CA · contact PI
27 Risk, Detection and Outcomes$18,707
P30 · FY2021 · CA · contact PI
27 Risk, Detection and Outcomes$18,676
P30 · FY2020 · CA · contact PI
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing$997,116
R01 · FY2019 · CA · contact PI
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer$336,500
R01 · FY2019 · CA
27 Risk, Detection and Outcomes$18,707
P30 · FY2019 · CA · contact PI
27 Risk, Detection and Outcomes$5,455
P30 · FY2019 · CA · contact PI
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer$346,909
R01 · FY2018 · CA
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing$3,203
R01 · FY2018 · CA · contact PI
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing$1,028,501
R01 · FY2017 · CA · contact PI
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer$346,909
R01 · FY2017 · CA · contact PI
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing$1,125,781
R01 · FY2016 · CA · contact PI
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer$360,634
R01 · FY2016 · CA · contact PI
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing$1,125,781
R01 · FY2015 · CA · contact PI
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data$374,395
R01 · FY2015 · HG · contact PI
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing$1,100,589
R01 · FY2014 · CA · contact PI
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data$376,477
R01 · FY2014 · HG · contact PI
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data$367,026
R01 · FY2013 · HG · contact PI
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data$384,477
R01 · FY2012 · HG · contact PI
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data$399,128
R01 · FY2011 · HG · contact PI
Identification of Rare Alleles for Genetic Association and Risk$44,725
R03 · FY2011 · CA · contact PI
Identification of Rare Alleles for Genetic Association and Risk$79,000
R03 · FY2010 · CA · contact PI